Amgen Shares Surge on Strong Earnings and Raised Guidance

Amgen (AMGN) shares have surged by 5.5% as investors react to strong quarterly earnings and an elevated full-year outlook, according to analysis from Quiver Quantitative.

The company reported a notable earnings beat, with quarterly EPS of $6.29 versus an estimate near $5.62, indicating a significant increase in profitability.

Amgen has also lifted its 2026 guidance, projecting revenue between $38.2 billion and $39.4 billion and non-GAAP EPS between $22.30 and $23.50.